Waycross Partners, LLC Bristol Myers Squibb CO Transaction History

Waycross Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	BUY	$61.91 - $67.42 $207,831 - $226,328	3,357 Added 279.75%	4,557 $304,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $207,831 - $226,328	-3,357 Reduced 73.67%	1,200 $1.86 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $263,121 - $298,164	4,557 New	4,557 $283,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Waycross Partners, LLC with notifications on news.